Want to join the conversation?
$TMK 2Q15 Call: Premium revenue for Medicare Part D declined 11% to $75MM. The underwriting margin for second quarter 2015 was $5MM, down from $9MM. The decline in underwriting margin was in line with our expectations was due to the increase in the Part D Drug costs. Net sales were $11MM, compared to $20MM in the year-ago quarter.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.